E13.3 Category · further specificity required Other specified diabetes mellitus with ophthalmic complications
ICD-10-CM E13.3 identifies “Other specified diabetes mellitus with ophthalmic complications” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 4: Endocrine, nutritional and metabolic diseases
Code-level instructions
No additional notes.
Inherited instructions
E13 · Other specified diabetes mellitus
Includes5
- diabetes mellitus due to genetic defects of beta-cell function
- diabetes mellitus due to genetic defects in insulin action
- postpancreatectomy diabetes mellitus
- postprocedural diabetes mellitus
- secondary diabetes mellitus NEC
Excludes 17
- diabetes (mellitus) due to autoimmune process (E10.-)
- diabetes (mellitus) due to immune mediated pancreatic islet beta-cell destruction (E10.-)
- diabetes mellitus due to underlying condition (E08.-)
- drug or chemical induced diabetes mellitus (E09.-)
- gestational diabetes (O24.4-)
- neonatal diabetes mellitus (P70.2)
- type 1 diabetes mellitus (E10.-)
Chapters 4 · Endocrine, nutritional and metabolic diseases (E00-E89)
Excludes 11
transitory endocrine and metabolic disorders specific to newborn (P70-P74)
Note1
All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
More specific codes
E13.31Other specified diabetes mellitus with unspecified diabetic retinopathyCategory · further specificity requiredE13.32Other specified diabetes mellitus with mild nonproliferative diabetic retinopathyCategory · further specificity requiredE13.33Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathyCategory · further specificity requiredE13.34Other specified diabetes mellitus with severe nonproliferative diabetic retinopathyCategory · further specificity requiredE13.35Other specified diabetes mellitus with proliferative diabetic retinopathyCategory · further specificity requiredE13.36Other specified diabetes mellitus with diabetic cataractBillable / specificE13.37Other specified diabetes mellitus with diabetic macular edema, resolved following treatmentCategory · further specificity requiredE13.39Other specified diabetes mellitus with other diabetic ophthalmic complicationBillable / specificOfficial index references
References from other codes (2)
Excludes 1 · diabetic retinopathy (E08.3-, E09.3-, E10.3-, E11.3-, E13.3-)
Excludes 2 · diabetes mellitus related eye conditions (E09.3-, E10.3-, E11.3-, E13.3-)
History
Code history
Latest recorded change · FY2025
Effective from
- Inherited rules changed
Other specified diabetes mellitus with ophthalmic complications
Category — select a more specific code
CDC/NCHS · FY2025All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | Inherited rules changed |
| FY2018 | 2017-10-01 | Inherited rules changed |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | Inherited rules changed |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Explore the more specific codes in this category. Reference checks do not establish clinical appropriateness or guarantee reimbursement.